CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II

NCT04516993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Tenecteplase
DRUG: The best treatment selected by local doctors(Aspirin, Recombinant Tissue Plasminogen Activator, Urokinase, Thrombectomy)

Sponsor

Huashan Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]